A DirEct to PatieNt Study in Chronic Pain

Boston Scientific Corporation1 site in 1 country50,000 target enrollmentJanuary 10, 2023

ConditionsChronic Pain

InterventionsCommercially Approved Interventional Medical Device/Therapy for Chronic Pain

Overview

Phase: Not Applicable
Intervention: Commercially Approved Interventional Medical Device/Therapy for Chronic Pain
Conditions: Chronic Pain
Sponsor: Boston Scientific Corporation
Enrollment: 50000
Locations: 1
Primary Endpoint: Change in pain post procedure
Status: Recruiting
Last Updated: 26 days ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Registry

clinicaltrials.gov

Start Date

January 10, 2023

End Date

December 1, 2029

Last Updated

26 days ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Boston Scientific Corporation

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
•Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
•Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English